Tadataka Yamada, Ph.D., Former Head of GlaxoSmithKline and Takeda R&D, Re-Joins Frazier Healthcare
Sika Boosted in Battle to Fend Off Saint-Gobain Takeover Bid--Update
Sika Boosted in Battle to Fend Off Saint-Gobain Takeover Bid
New Jersey's Hart and Celgene and Johnson & Johnson Executives Named to Scientific American Worldview 100 Most Influential People in Biotechnology
Saudi Prince Pledges $32 Billion to Good Causes With Women's Rights a Focus
Synlogic to Present at Several Upcoming Scientific and Industry Conferences
Mark Zuckerberg, Wife Donate $5 Million to TheDream.US
Although the public is still uncertain who will succeed the Oracle, the split-up of the chairman, CEO, and investment roles likely won't alter Berkshire's overall strategy.
Opinions and statements of financial market trends that are based on current market conditions constitute our judgment and are subject to change without notice. We believe the information provided here is reliable but should not be assumed to be accurate or complete. The views and strategies ...